3UTR - Tissue-specific choice of 3
From 01-01-2009 to 31-12-2012
Description
Recent investigation in our laboratory on a large set of microarray experiments from a panel of 24 mouse tissues/organs indicated that at least 600 genes are differentially expressed by a tissue-specific choice of length of the 3’ untranslated region (3’UTR) of mRNA.Even for the most ubiquitously used genes such as those encoding ribosomal proteins and subunits of the mitochondrial respiratory chain, the Affymetrix 430 2.0 arrays, which are primarily directed against the 3’ end of transcripts, revealed considerable variation across different mouse tissues (Thorrez et al (2008) PloS ONE in press). This suggests that also form any other housekeeping genes transcript variants exist that can be identical for the protein coding information, but are different in 3’UTR length. It is now generally accepted that the3’UTR plays a role in post-transcriptional regulation of mRNA, influencing life-span, translation and transport of the transcript. The molecular mechanism of this regulation relies on bindingsites within the 3’UTR sequence for microRNAs and RNA-binding proteins. MicroRNAs are small (21-23 nt) non-protein coding RNAs that regulate mRNA stability and translation of target transcripts.
The human genome currently is known to harbor 541 miRNA genes (MirBase:http://microrna.sanger.ac.uk/) and some of these are expressed in a tissue-specific manner(Landgraf et al (2007) Cell 129: 1401-1414). Furthermore, there are dozens of known 3’UTRmRNAbinding proteins that affect mRNA life span, or regulate subcellular localization (e.g. inneurons) or protein translation (McKee et al (2007) Cell Res 17:581-90). One early discovered example of such regulation in pancreatic beta cells involves the pyrimidine tract binding proteinPTB1 that is important for glucose and incretin hormone-dependent post-transcriptional regulation of insulin-biosynthesis (Knoch et al (2004) Nat Cell Biol. 6:207-214; Knoch et al(2006) Cell Metab. 3:123-134).
Another example of an mRNA binding protein is pumilio-2which plays an important role in proliferation and self-renewal of stem cells (Crittenden SL et al(2002) Nature 417(6889):660-663; www.genecards.org) and brain function (Muraro et al (2008)J Neurosci 28:2099-2109). This protein regulates translation of its target that it recognizes via16 nt motif in the 3’UTR that is similar to Nanos Response Element (Moore et al (2003) PNAS100: 538-543).
Team
- Yves Moreau, Co-promoter
- Lieven Thorrez, Coordinator
- Frans Schuit, Promoter (External)
- Sonia Leach, Team member
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Research Grant - FWO Research Grant
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.